ATE395933T1 - Präventiva oder arzneien enthaltend neutralisierende anti-il6-rezeptor antikörper zur reduktion urinären proteins bei systemischen lupus erythematosus - Google Patents
Präventiva oder arzneien enthaltend neutralisierende anti-il6-rezeptor antikörper zur reduktion urinären proteins bei systemischen lupus erythematosusInfo
- Publication number
- ATE395933T1 ATE395933T1 AT98937834T AT98937834T ATE395933T1 AT E395933 T1 ATE395933 T1 AT E395933T1 AT 98937834 T AT98937834 T AT 98937834T AT 98937834 T AT98937834 T AT 98937834T AT E395933 T1 ATE395933 T1 AT E395933T1
- Authority
- AT
- Austria
- Prior art keywords
- lupus erythematosus
- systemic lupus
- preventives
- receptor antibodies
- neutralizing anti
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22040097 | 1997-08-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE395933T1 true ATE395933T1 (de) | 2008-06-15 |
Family
ID=16750530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98937834T ATE395933T1 (de) | 1997-08-15 | 1998-08-14 | Präventiva oder arzneien enthaltend neutralisierende anti-il6-rezeptor antikörper zur reduktion urinären proteins bei systemischen lupus erythematosus |
Country Status (12)
Country | Link |
---|---|
EP (2) | EP1004315B1 (de) |
JP (4) | JP2009185073A (de) |
KR (5) | KR20100068498A (de) |
AT (1) | ATE395933T1 (de) |
AU (1) | AU747883B2 (de) |
CA (1) | CA2296322A1 (de) |
CY (1) | CY1108180T1 (de) |
DE (1) | DE69839517D1 (de) |
DK (1) | DK1004315T3 (de) |
ES (1) | ES2308809T3 (de) |
PT (1) | PT1004315E (de) |
WO (1) | WO1999008707A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR048335A1 (es) | 2004-03-24 | 2006-04-19 | Chugai Pharmaceutical Co Ltd | Agentes terapeuticos para trastornos del oido interno que contienen un antagonista de il- 6 como un ingrediente activo |
ES2568436T3 (es) | 2006-03-31 | 2016-04-29 | Chugai Seiyaku Kabushiki Kaisha | Procedimiento para controlar la farmacocinética en sangre de anticuerpos |
US8080248B2 (en) | 2006-06-02 | 2011-12-20 | Regeneron Pharmaceuticals, Inc. | Method of treating rheumatoid arthritis with an IL-6R antibody |
RS52643B (en) | 2006-06-02 | 2013-06-28 | Regeneron Pharmaceuticals Inc. | HIGH AFINITY ANTIBODIES TO THE HUMAN IL-6 RECEPTOR |
GB0717337D0 (en) | 2007-09-06 | 2007-10-17 | Ucb Pharma Sa | Method of treatment |
SG10201605394SA (en) | 2007-09-26 | 2016-08-30 | Chugai Pharmaceutical Co Ltd | Modified Antibody Constant Region |
EP3689912A1 (de) | 2007-09-26 | 2020-08-05 | Chugai Seiyaku Kabushiki Kaisha | Verfahren zur modifizierung eines isoelektrischen punkts eines antikörpers über aminosäuresubstitution in cdr |
EP4238993A3 (de) | 2008-04-11 | 2023-11-29 | Chugai Seiyaku Kabushiki Kaisha | Antigenbindendes molekül zur wiederholten bindung an zwei oder mehr antigenmoleküle |
TWI440469B (zh) | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
JO3417B1 (ar) | 2010-01-08 | 2019-10-20 | Regeneron Pharma | الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r |
SG190727A1 (en) | 2010-11-30 | 2013-07-31 | Chugai Pharmaceutical Co Ltd | Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly |
TWI589299B (zh) | 2011-10-11 | 2017-07-01 | 再生元醫藥公司 | 用於治療類風濕性關節炎之組成物及其使用方法 |
CN103169966B (zh) * | 2013-04-09 | 2015-04-01 | 中国人民解放军军事医学科学院基础医学研究所 | 一种治疗系统性红斑狼疮的药物组合物 |
WO2014200018A1 (ja) | 2013-06-11 | 2014-12-18 | 独立行政法人 国立精神・神経医療研究センター | 再発寛解型多発性硬化症(rrms)患者の治療予後予測方法、及び新規治療適応判断方法 |
US9017678B1 (en) | 2014-07-15 | 2015-04-28 | Kymab Limited | Method of treating rheumatoid arthritis using antibody to IL6R |
TW202339800A (zh) | 2015-02-27 | 2023-10-16 | 日商中外製藥股份有限公司 | Il-6受體抗體用於製備醫藥組成物的用途 |
US10697883B2 (en) | 2015-05-19 | 2020-06-30 | National Center Of Neurology And Psychiatry | Method for determining application of therapy to multiple sclerosis (MS) patient |
US11851486B2 (en) | 2017-05-02 | 2023-12-26 | National Center Of Neurology And Psychiatry | Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils |
US11692037B2 (en) | 2017-10-20 | 2023-07-04 | Hyogo College Of Medicine | Anti-IL-6 receptor antibody-containing medicinal composition for preventing post-surgical adhesion |
JP2022519828A (ja) | 2019-01-31 | 2022-03-25 | サノフィ・バイオテクノロジー | 若年性特発性関節炎を治療するための抗il-6受容体抗体 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US521628A (en) | 1894-06-19 | Housekeeping-cabinet | ||
JPS58201994A (ja) | 1982-05-21 | 1983-11-25 | Hideaki Hagiwara | 抗原特異的ヒト免疫グロブリンの生産方法 |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
JPH02500329A (ja) | 1987-05-21 | 1990-02-08 | クリエイテイブ・バイオマリキユールズ・インコーポレーテツド | ターゲット化多機能蛋白質 |
CA1341152C (en) | 1988-01-22 | 2000-12-12 | Tadamitsu Kishimoto | Receptor protein for human b cell stimulatory factor-2 |
DE3835350A1 (de) | 1988-10-17 | 1990-04-19 | Boehringer Mannheim Gmbh | Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern |
JP2803199B2 (ja) * | 1989-08-07 | 1998-09-24 | 株式会社ニコン | カメラの警告装置 |
JPH03155795A (ja) | 1989-11-13 | 1991-07-03 | Chuzo Kishimoto | マウス・インターロイキン―6レセプター蛋白質 |
ES2108048T3 (es) | 1990-08-29 | 1997-12-16 | Genpharm Int | Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos. |
US5525491A (en) | 1991-02-27 | 1996-06-11 | Creative Biomolecules, Inc. | Serine-rich peptide linkers |
WO1992019759A1 (en) | 1991-04-25 | 1992-11-12 | Chugai Seiyaku Kabushiki Kaisha | Reconstituted human antibody against human interleukin 6 receptor |
CA2124967C (en) | 1991-12-17 | 2008-04-08 | Nils Lonberg | Transgenic non-human animals capable of producing heterologous antibodies |
CA2140638C (en) | 1992-07-24 | 2010-05-04 | Raju Kucherlapati | Generation of xenogeneic antibodies |
FR2694767B1 (fr) * | 1992-08-13 | 1994-10-21 | Innotherapie Lab Sa | Anticorps monoclonaux anti-IL6R, et leurs applications. |
US5648267A (en) | 1992-11-13 | 1997-07-15 | Idec Pharmaceuticals Corporation | Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same |
CA2161351C (en) | 1993-04-26 | 2010-12-21 | Nils Lonberg | Transgenic non-human animals capable of producing heterologous antibodies |
WO1996011020A1 (fr) * | 1994-10-07 | 1996-04-18 | Chugai Seiyaku Kabushiki Kaisha | Medicament contre la polyarthrite rhumatoide contenant un antagoniste d'interleukine 6 comme principe actif |
WO1995009873A1 (en) | 1993-10-06 | 1995-04-13 | Board Of Regents, The University Of Texas System | A monoclonal anti-human il-6 receptor antibody |
WO1996012503A1 (fr) * | 1994-10-21 | 1996-05-02 | Chugai Seiyaku Kabushiki Kaisha | Remede contre des maladies provoquees par la production d'il-6 |
ES2264135T3 (es) * | 1995-02-13 | 2006-12-16 | Chugai Seiyaku Kabushiki Kaisha | Inhibidor de la descomposicion de proteinas musculares que contienen anticuerpos frente al receptor de il-6. |
EP0817794A1 (de) | 1995-03-31 | 1998-01-14 | Jakob Bohr | Verfahren zur (rück) faltung der proteine |
CA2219361C (en) | 1995-04-27 | 2012-02-28 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
EP0823941A4 (de) | 1995-04-28 | 2001-09-19 | Abgenix Inc | Menschliche antikörper aus xenomäusen |
JP2005247872A (ja) * | 1997-08-15 | 2005-09-15 | Chugai Pharmaceut Co Ltd | 抗il−6レセプター抗体を有効成分として含有する全身性エリテマトーデスの予防および/または治療剤 |
JP3803199B2 (ja) * | 1997-08-15 | 2006-08-02 | 中外製薬株式会社 | 抗il−6レセプター抗体を有効成分として含有する全身性エリテマトーデスの予防および/または治療剤 |
-
1998
- 1998-08-14 CA CA002296322A patent/CA2296322A1/en not_active Abandoned
- 1998-08-14 AU AU86494/98A patent/AU747883B2/en not_active Ceased
- 1998-08-14 KR KR1020107012126A patent/KR20100068498A/ko active Search and Examination
- 1998-08-14 PT PT98937834T patent/PT1004315E/pt unknown
- 1998-08-14 KR KR1020087004911A patent/KR20080027967A/ko not_active Application Discontinuation
- 1998-08-14 WO PCT/JP1998/003636 patent/WO1999008707A1/ja active IP Right Grant
- 1998-08-14 EP EP98937834A patent/EP1004315B1/de not_active Revoked
- 1998-08-14 ES ES98937834T patent/ES2308809T3/es not_active Expired - Lifetime
- 1998-08-14 DK DK98937834T patent/DK1004315T3/da active
- 1998-08-14 KR KR10-2003-7016315A patent/KR20040024561A/ko not_active Application Discontinuation
- 1998-08-14 AT AT98937834T patent/ATE395933T1/de active
- 1998-08-14 DE DE69839517T patent/DE69839517D1/de not_active Expired - Lifetime
- 1998-08-14 KR KR1020007001448A patent/KR20010022846A/ko active Search and Examination
- 1998-08-14 EP EP08001023A patent/EP1916020A3/de not_active Ceased
- 1998-08-14 KR KR1020097011311A patent/KR20090068385A/ko not_active IP Right Cessation
-
2008
- 2008-07-08 CY CY20081100714T patent/CY1108180T1/el unknown
-
2009
- 2009-05-25 JP JP2009125791A patent/JP2009185073A/ja not_active Withdrawn
-
2012
- 2012-08-10 JP JP2012178718A patent/JP2012214517A/ja not_active Withdrawn
-
2015
- 2015-02-25 JP JP2015035784A patent/JP2015098491A/ja not_active Withdrawn
-
2016
- 2016-10-07 JP JP2016199315A patent/JP2017002087A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE69839517D1 (de) | 2008-07-03 |
WO1999008707A1 (fr) | 1999-02-25 |
KR20090068385A (ko) | 2009-06-26 |
EP1004315B1 (de) | 2008-05-21 |
EP1004315A4 (de) | 2001-12-05 |
DK1004315T3 (da) | 2008-07-21 |
KR20010022846A (ko) | 2001-03-26 |
EP1916020A2 (de) | 2008-04-30 |
AU747883B2 (en) | 2002-05-30 |
JP2017002087A (ja) | 2017-01-05 |
EP1004315A1 (de) | 2000-05-31 |
JP2009185073A (ja) | 2009-08-20 |
JP2012214517A (ja) | 2012-11-08 |
CA2296322A1 (en) | 1999-02-25 |
PT1004315E (pt) | 2008-07-09 |
KR20100068498A (ko) | 2010-06-23 |
JP2015098491A (ja) | 2015-05-28 |
AU8649498A (en) | 1999-03-08 |
EP1916020A3 (de) | 2008-07-02 |
KR20040024561A (ko) | 2004-03-20 |
ES2308809T3 (es) | 2008-12-01 |
KR20080027967A (ko) | 2008-03-28 |
CY1108180T1 (el) | 2014-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE395933T1 (de) | Präventiva oder arzneien enthaltend neutralisierende anti-il6-rezeptor antikörper zur reduktion urinären proteins bei systemischen lupus erythematosus | |
DE69839992D1 (de) | Vorbeugende- oder Heilmittel zur Behandlung von Multipler Sklerose, mit antagonistischen anti-IL6-Rezeptor Antikörpern als Wirkstoff | |
AU1095202A (en) | Preventives or remedies for psoriasis containing as the active ingredient il-6 antagonist | |
IT1289728B1 (it) | Dispositivo di impianto e corredo che lo comprende | |
LV12452A (lv) | Aktivas vielas vaginala ievadisanas sistema | |
ATE350060T1 (de) | Mittel zur vorbeugung oder behandlung von pankreatitis die anti-il-6 receptor antikörper als aktive komponente enthalten | |
BR9610875A (pt) | Modulares rxr seletivos - dimeros e processos para seu uso | |
ATE383875T1 (de) | Prophylaktische oder therapeutische mittel gegen entzündliche erkrankungen des verdauungstraktes enthaltend antagonistische il-6 rezeptor antikörper | |
DE69319824T2 (de) | Vorrichtung zur Regulierung der Urin-Inkontinenz bei Frauen | |
DE69732444D1 (de) | Vorrichtung für aktives Implantat | |
AU2967692A (en) | Improved composition and device for urinary protein assay and method of using the same | |
DE69329407T2 (de) | Verfahren und Implantatvorrichtung für Langzeitwirkstoffabgabe | |
BR9811094A (pt) | Agente terapêutico para tumores linfáticos | |
EP1041994A4 (de) | Verwendung von parasitären biologischen wirkstoffen zur vorbeugung und kontrolle von autoimmunkrankheiten | |
ES2164434T3 (es) | Tratamiento topico de psoriasis que utiliza anticuerpos neutralizantes de il-8. | |
AU3552389A (en) | An agent for desensitizing man and/or animals against an allergen | |
NO870191L (no) | Ionestraale implanteringssystem. | |
AU2001285835A1 (en) | Device and method for raising an animal's hoof | |
NL193764B (nl) | Halfgeleiderinrichting en werkwijze voor het maken daarvan. | |
ITBO910198A1 (it) | Metodo e dispositivo per il controllo dell'integrita' esteriore di sigarette. | |
AU5388299A (en) | Antibodies for use in targeted and temporary treatment of humans and animals | |
IT1297168B1 (it) | Dispositivo e metodo di preparazione per l'impianto di stents biforcati | |
ITMI930820A0 (it) | Dispositivo di comando dell'acceleratore per autovetture per disabili | |
ATE51512T1 (de) | Klebstofflose gelenkpfannenkonstruktion fuer prothesen, sowie vorrichtung zur implantation. | |
LV5683A3 (lv) | Daleji gredzenveidigs linearais lodisu ieliktnis un gareniska aizdarsloksne tam |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1004315 Country of ref document: EP |